Crinetics Pharmaceuticals (CRNX) Gains from Investment Securities (2017 - 2026)
Crinetics Pharmaceuticals' quarterly Gains from Investment Securities came in at -$20000.0 in Q1 2026, down 100.13% year-on-year from $15.3 million in Q1 2025, and down 147.62% quarter-over-quarter from $42000.0 in Q4 2025.
Crinetics Pharmaceuticals has reported Gains from Investment Securities for 10 years, with the latest figure at -$20000.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Investment Securities fell 100.13% year-over-year to -$20000.0; the trailing twelve-month figure through Mar 2026 stood at $73000.0 (down 99.52% YoY), and the FY2024 full-year result was $13.7 million, up 8.23% from the prior year.
- Gains from Investment Securities for Q1 2026 stood at -$20000.0, down from $42000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $46.3 million in Q4 2023, with the low at -$5.6 million in Q4 2022.
- Average Gains from Investment Securities over 5 years is $8.3 million, with a median of $4.1 million recorded in 2023.
- Peak annual rise in Gains from Investment Securities reached 343359.55% in 2022, while the deepest fall reached 70100.0% in 2022.
- Tracing CRNX's Gains from Investment Securities over 5 years: stood at -$5.6 million in 2022, then surged by 926.41% to $46.3 million in 2023, then sank by 99.89% to $51000.0 in 2024, then slipped by 17.65% to $42000.0 in 2025, then slumped by 147.62% to -$20000.0 in 2026.
- The last three Gains from Investment Securities figures came in at -$20000.0 (Q1 2026), $42000.0 (Q4 2025), and $15.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Crinetics Pharmaceuticals | 3.59 Bn | 3.59 Bn | 10.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20,000.00 |
| Mar 31, 2026 | -20,000.00 |
| Dec 31, 2025 | 42,000.00 |
| Dec 31, 2025 | 42,000.00 |
| Jun 30, 2025 | 14.99 Mn |
| Jun 30, 2025 | 14.99 Mn |
| Mar 31, 2025 | 15.29 Mn |
| Mar 31, 2025 | 15.29 Mn |
| Dec 31, 2024 | 51,000.00 |
| Dec 31, 2024 | 51,000.00 |
| Sep 30, 2024 | 5.00 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Jun 30, 2024 | 14.14 Mn |
| Jun 30, 2024 | 14.14 Mn |
| Mar 31, 2024 | 13.80 Mn |
| Mar 31, 2024 | 13.80 Mn |
| Dec 31, 2023 | 46.28 Mn |
| Dec 31, 2023 | 46.28 Mn |
| Sep 30, 2023 | 12.46 Mn |
| Sep 30, 2023 | 12.46 Mn |
| Jun 30, 2023 | 3.23 Mn |
| Jun 30, 2023 | 3.23 Mn |
| Mar 31, 2023 | 100,000.00 |
| Mar 31, 2023 | 100,000.00 |
| Dec 31, 2022 | -5.60 Mn |
| Dec 31, 2022 | -5.60 Mn |
| Sep 30, 2022 | 8.90 Mn |
| Sep 30, 2022 | 8.90 Mn |
| Jun 30, 2022 | 2.53 Mn |
| Jun 30, 2022 | 2.53 Mn |
| Mar 31, 2022 | 1.65 Mn |
| Mar 31, 2022 | 1.65 Mn |
| Dec 31, 2021 | 8,000.00 |
| Dec 31, 2021 | 8,000.00 |
| Sep 30, 2021 | 2,591.00 |
| Sep 30, 2021 | 2,591.00 |
| Jun 30, 2021 | 1,901.00 |
| Jun 30, 2021 | 1,901.00 |
| Mar 31, 2021 | 100,000.00 |
| Mar 31, 2021 | 100,000.00 |
| Dec 31, 2020 | -1,000.00 |
| Dec 31, 2020 | -1,000.00 |
| Sep 30, 2020 | 4,224.00 |
| Sep 30, 2020 | 4,224.00 |
| Jun 30, 2020 | 1,019.00 |
| Jun 30, 2020 | 1,019.00 |
| Mar 31, 2020 | 3,869.00 |
| Mar 31, 2020 | 3,869.00 |
| Dec 31, 2019 | 7,000.00 |
| Dec 31, 2019 | 7,000.00 |
| Sep 30, 2019 | 9,119.00 |
| Sep 30, 2019 | 9,119.00 |
| Jun 30, 2019 | 773,125.00 |
| Jun 30, 2019 | 773,125.00 |
| Mar 31, 2019 | 2.92 Mn |
| Mar 31, 2019 | 2.92 Mn |
| Dec 31, 2018 | 2.41 Mn |
| Dec 31, 2018 | 2.41 Mn |
| Sep 30, 2018 | 2.29 Mn |
| Sep 30, 2018 | 2.29 Mn |
| Jun 30, 2018 | 2.27 Mn |
| Jun 30, 2018 | 2.27 Mn |
| Mar 31, 2018 | -2,000.00 |
| Mar 31, 2018 | -2,000.00 |
| Dec 31, 2017 | 838,276.00 |
| Dec 31, 2017 | 838,276.00 |